Pano Therapeutics
overview team News contact
overviewteamNewscontact
Pano Therapeutics
Address Complex Disease of Aging by Modulating the Mitochondrial Proton Motive Force
 

News

 
 
 
Featured
Apr 25, 2022
PANO THERAPEUTICS, INC. ANNOUNCES THE STRATEGIC ACQUISITION OF NOVATARG THERAPEUTICS, INC. AND THE APPOINTMENT OF KEN BATCHELOR, PHD AS HEAD OF RESEARCH & DEVELOPMENT.
Apr 25, 2022
Apr 25, 2022
 
overviewteamNewscontact

© 2025 Pano Therapeutics, Inc

50.png